首页> 外文会议>The 7th international medicinal mushroom conference >Hypoglycemic Effect of Ganoderma lucidum Purified Polysaccharide F31 Targeted Glucose-6-Phosphatase-Catalytic Protein in Type 2 Diabetic Mice
【24h】

Hypoglycemic Effect of Ganoderma lucidum Purified Polysaccharide F31 Targeted Glucose-6-Phosphatase-Catalytic Protein in Type 2 Diabetic Mice

机译:灵芝纯化的多糖F31靶向葡萄糖6-磷酸酶催化蛋白在2型糖尿病小鼠中的降血糖作用

获取原文
获取原文并翻译 | 示例

摘要

Previous studies have demonstrated that Ganoderma lucidum polysaccharides (GLPs) have hypoglycemic effects in type 2 diabetic mice.This study aimed to investigate the hypoglycemic effects and mechanisms of action of Ganoderma lucidum purified polysaccharides-enriched fraction from GLPs in type 2 diabetic mice.GLPs were applied onto a column of deaerator (DEAE) Sepharose Fast Flow chromatography,then onto gel filtration-Sephacryl S300.Four purified polysaccharide fractions named F21,F22,F31 and F32 were obtained.The mice were randomLy divided into 6 groups (8 mice/group).The 6 groups were as follows:normal control group,diabetic control group,F21-treated diabetic group [50 milligrams/kilograms/day (mg/kg/d)],F22-treated diabetic group (50 mg/kg/d),F31-treated diabetic group (50 mg/kg/d) and F32-treated diabetic group (50 mg/kg/d).Diabetes was induced via streptozotocin (STZ) injection and high-fat dietary feeding.In seven days following the STZ injection,fasting serum glucose and insulin levels were measured.The hepatic messenger ribonucleic acid (mRNA) levels of glycogen phosphorylase (GP),fructose-l,6-bisphosphatase (FBPase),phosphoenolpyruvate carboxykinase (PEPCK),glucose-6-phosphatase (G6Pase,including G6Pase-catalytic protein and a specific transporter named G6Pase-T1) were determined by real-time polymerase chain reaction (RT-PCR).Results showed that F31 significantly decreased fasting serum glucose compared with the diabetic control group (p<0.05),and simultaneously decreased the hepatic mRNA levels of GP,FBPase,PEPCK and G6Pase (p<0.01).In contrast to F21,F22,and F32,only F31 significantly decreased mRNA levels of G6Pase-catalytic protein.Taken together,the decreases in fasting serum glucose levels may be associated with decreased mRNA levels of G6Pase-catalytic protein,indicating that G6Pase-catalytic protein may be the key factor of glucose regulatory enzymes due to hypoglycemic effect.The structural characteristics of F31 were investigated by gel permeation chromatography (GPC),Fourier transform infrared (FTIR),nuclear magnetic resonance (NMR) and gas chromatography mass spectrometry (GC-MS).Based on the data obtained,F31 was determined to be a β-heteropolysaccharide composed of glucose,mannose,xylose,arabinose and galactose with the kilo Dalton molecular weight (kDa) of 15.9.
机译:先前的研究表明,灵芝多糖(GLP)在2型糖尿病小鼠中具有降血糖作用,本研究旨在研究灵芝纯化的富含GLP的多糖在2型糖尿病小鼠中的降血糖作用及其作用机制。将其应用于脱气器(DEAE)Sepharose Fast Flow色谱柱上,然后进行凝胶过滤-Sephacryl S300,获得了四个纯化的多糖组分F21,F22,F31和F32。小鼠随机分为6组(每组8只小鼠) )分为6组:正常对照组,糖尿病对照组,F21治疗糖尿病组[50毫克/千克/天(mg / kg / d)],F22治疗糖尿病组(50mg / kg / d)。 ),F31治疗的糖尿病组(50 mg / kg / d)和F32治疗的糖尿病组(50 mg / kg / d)。通过链脲佐菌素(STZ)注射和高脂饮食喂养诱导糖尿病。 STZ注射,空腹血糖和胰岛素测定n水平。肝糖原磷酸化酶(GP),果糖-1,6-双磷酸酶(FBPase),磷酸烯醇丙酮酸羧化激酶(PEPCK),葡萄糖-6-磷酸酶(G6Pase,包括G6Pase催化)的信使核糖核酸(mRNA)水平通过实时聚合酶链反应(RT-PCR)测定蛋白和特定的转运蛋白G6Pase-T1。结果显示,F31与糖尿病对照组相比显着降低了空腹血糖(p <0.05),同时降低了空腹血糖。肝中GP,FBPase,PEPCK和G6Pase的mRNA水平(p <0.01)。与F21,F22和F32相比,只有F31显着降低G6Pase催化蛋白的mRNA水平。综合而言,空腹血糖水平可能降低与降糖作用有关,表明G6Pase催化蛋白可能是葡萄糖调节酶的关键因素。凝胶渗透法研究了F31的结构特征色谱(GPC),傅立叶变换红外光谱(FTIR),核磁共振(NMR)和气相色谱质谱(GC-MS)。根据所得数据,F31被确定为由葡萄糖,甘露糖组成的β-杂多糖,木糖,阿拉伯糖和半乳糖,其道尔顿分子量(kDa)为15.9。

著录项

  • 来源
  • 会议地点 Beijing(CN)
  • 作者单位

    Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, State Key Laboratory of Applied Microbiology(Ministry of Guangdong Province Joint Breeding Base), South China, Guangdong Institute of Microbiology, Guangzhou 510070, China;

    Department of Toxicology, Center for Disease Control and Prevention of Guangdong Province, Guangzhou 510020, China;

    Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, State Key Laboratory of Applied Microbiology(Ministry of Guangdong Province Joint Breeding Base), South China, Guangdong Institute of Microbiology, Guangzhou 510070, China;

    Guangdong Institute of Microbiology, Xianlie Central Road 100, Guangzhou 510070, China;

    a Joint first authors;

    Department of Toxicology, Center for Disease Control and Prevention of Guangdong Province, Guangzhou 510020, China;

    Department of Toxicology, Center for Disease Control and Prevention of Guangdong Province, Guangzhou 510020, China;

    Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, State Key Laboratory of Applied Microbiology(Ministry of Guangdong Province Joint Breeding Base), South China, Guangdong Institute of Microbiology, Guangzhou 510070, China;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 中药材;
  • 关键词

    Ganoderma lucidum polysaccharides; hypoglycemic activity; Type 2 diabetes mellitus; hypoglycemic mechanism;

    机译:灵芝多糖;降血糖活动; 2型糖尿病;降糖机制;
  • 入库时间 2022-08-26 14:04:25

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号